Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial
Publication
, Conference
Hijazi, Z; Hohnloser, SH; Andersson, U; Alexander, JH; Granger, CB; Hanna, M; Lopes, RD; Siegbahn, A; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2015
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2015
Volume
36
Start / End Page
339 / 339
Location
London, ENGLAND
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hijazi, Z., Hohnloser, S. H., Andersson, U., Alexander, J. H., Granger, C. B., Hanna, M., … Wallentin, L. (2015). Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 36, pp. 339–339). London, ENGLAND: OXFORD UNIV PRESS.
Hijazi, Z., S. H. Hohnloser, U. Andersson, J. H. Alexander, C. B. Granger, M. Hanna, R. D. Lopes, A. Siegbahn, and L. Wallentin. “Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 36:339–339. OXFORD UNIV PRESS, 2015.
Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Granger CB, Hanna M, et al. Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 339–339.
Hijazi, Z., et al. “Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 36, OXFORD UNIV PRESS, 2015, pp. 339–339.
Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Granger CB, Hanna M, Lopes RD, Siegbahn A, Wallentin L. Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation: Insights from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 339–339.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2015
Volume
36
Start / End Page
339 / 339
Location
London, ENGLAND
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology